Function and Mechanism of CUL4 E3 Ligases in Human Diseases

CUL4 E3 连接酶在人类疾病中的功能和机制

基本信息

  • 批准号:
    8642184
  • 负责人:
  • 金额:
    $ 35.83万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-02-01 至 2016-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Most, if not all, cellular processes are regulated by timely degradation of regulatory proteins through the ubiquitin system. Specific substrate proteins are targeted for degradation through the activity of E3 ubiquitin ligases. We previously discovered that two small RING finger proteins, ROC1 and ROC2, function as the essential catalytic components of the largest family of E3 ligase complexes, the cullin-RING E3 ligases (CRLs). We also discovered that cullin 3 and cullin 4 could assemble as many as 200 and 100 distinct CRL3 and CRL4 E3 complexes, respectively. In this application, we propose two lines of research aimed at understanding the function and mechanism of two specific CRL4 E3 ubiquitin ligase complexes, CRL4G¿2, and CRL4WDR5, and how alterations of these CRL4 complexes contribute to two major human diseases, heart failure and X-linked mental retardation. In the first Aim, we will examine the molecular function of CRL4 G¿2 and its role in cardiovascular disease. We present data demonstrating that a WD40 protein, G-protein ¿ subunit 2 (G¿2), associates with DDB1- CUL4A to target G protein-coupled receptor kinases (GRK2), for ubiquitylation. Elevated GRK2 has previously been associated with myocardial infarction, heart failure, portal hypertension, insulin resistance, and Alzheimer's disease. We propose first to explore how broadly CRL4 is involved in the regulation of G- protein coupled receptor (GPCR) signaling by determining the interaction of CRL4 with other G¿ and GRK proteins. We will then focus on one well-characterized GPCR signaling pathway, ¿-adrenergic receptors (¿ - AR) signaling, to determine the mechanism of CRL4G¿2 mediated GRK2 ubiquitylation. We will also determine whether loss of Cul4a impairs heart function in mouse. In the second Aim, we present data demonstrating that CUL4B, one of the most frequently mutated genes in X-linked mental retardation (XLMR) patients, but not CUL4A, is a nuclear E3 ligase of WDR5, a WD40 protein and an essential component for histone H3K4 trimethylation. We propose to determine the function of CUL4B-mediated WDR5 ubiquitylation in neuronal cell proliferation, survival and differentiation. We also propose to develop and characterize a novel mouse model, conditional Cul4b mutant mouse strain, to determine the function of Cul4b in brain. Finally, we propose to determine broadly the function of CUL4B in the regulation of chromatin modification and gene expression.
描述(由申请人提供):大多数(如果不是全部)细胞过程通过泛素系统及时降解调节蛋白来调节。特异性底物蛋白通过E3泛素连接酶的活性靶向降解。我们以前发现,两个小的RING指蛋白,ROC 1和ROC 2,作为E3连接酶复合物的最大家族,cullin-RING E3连接酶(CRL)的基本催化组分。我们还发现cullin 3和cullin 4分别可以组装多达200个和100个不同的CRL 3和CRL 4 E3复合物。在本申请中,我们提出了两条研究路线,旨在了解两种特定的CRL 4 E3泛素连接酶复合物,CRL 4G <$2和CRL 4 WDR 5的功能和机制,以及这些CRL 4复合物的改变如何导致两种主要的人类疾病,心力衰竭和X连锁精神发育迟滞。在第一个目标中,我们将研究CRL 4 G <$2的分子功能及其在心血管疾病中的作用。我们目前的数据表明,WD 40蛋白,G蛋白亚基2(G <$2),与DDB 1-CUL 4A的目标G蛋白偶联受体激酶(GRK 2),泛素化。GRK 2升高以前与心肌梗死、心力衰竭、门脉高压、胰岛素抵抗和阿尔茨海默病有关。我们建议首先探索如何广泛的CRL 4参与G蛋白偶联受体(GPCR)信号的调节,通过确定CRL 4与其他G蛋白和GRK蛋白的相互作用。然后,我们将集中在一个充分表征的GPCR信号通路,<$-肾上腺素能受体(<$- AR)信号,以确定CRL 4G <$2介导的GRK 2泛素化的机制。我们还将确定Cul 4a的缺失是否损害小鼠的心脏功能。在第二个目标,我们目前的数据表明,CUL 4 B,最常见的突变基因之一,在X连锁精神发育迟滞(XLMR)患者,但不是CUL 4A,是一个核E3连接酶的WDR 5,WD 40蛋白和组蛋白H3 K4三甲基化的必要组成部分。我们建议确定CUL 4 B介导的WDR 5泛素化在神经细胞增殖,存活和分化中的功能。我们还建议开发和表征一种新的小鼠模型,条件Cul 4 b突变小鼠品系,以确定Cul 4 b在脑中的功能。最后,我们建议广泛地确定CUL 4 B在染色质修饰和基因表达调控中的功能。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YUE XIONG其他文献

YUE XIONG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YUE XIONG', 18)}}的其他基金

Mechanisms of Metabolic Gene Mutations in Cancer
癌症代谢基因突变的机制
  • 批准号:
    8611905
  • 财政年份:
    2012
  • 资助金额:
    $ 35.83万
  • 项目类别:
Mechanisms of Metabolic Gene Mutations in Cancer
癌症代谢基因突变的机制
  • 批准号:
    9010942
  • 财政年份:
    2012
  • 资助金额:
    $ 35.83万
  • 项目类别:
Mechanisms of Metabolic Gene Mutations in Cancer
癌症代谢基因突变的机制
  • 批准号:
    8434844
  • 财政年份:
    2012
  • 资助金额:
    $ 35.83万
  • 项目类别:
Mechanisms of Metabolic Gene Mutations in Cancer
癌症代谢基因突变的机制
  • 批准号:
    8219796
  • 财政年份:
    2012
  • 资助金额:
    $ 35.83万
  • 项目类别:
Cancer Cell Biology
癌细胞生物学
  • 批准号:
    8340183
  • 财政年份:
    2011
  • 资助金额:
    $ 35.83万
  • 项目类别:
Program Leaders
项目负责人
  • 批准号:
    8340160
  • 财政年份:
    2011
  • 资助金额:
    $ 35.83万
  • 项目类别:
The Cullin-ROC Family of E3 Ubiquitin Ligases
E3 泛素连接酶的 Cullin-ROC 家族
  • 批准号:
    8085407
  • 财政年份:
    2010
  • 资助金额:
    $ 35.83万
  • 项目类别:
The Physiological Function and Regulation of INK4 Genes
INK4基因的生理功能及调控
  • 批准号:
    7913867
  • 财政年份:
    2009
  • 资助金额:
    $ 35.83万
  • 项目类别:
The ROC-Cullin Family of E3 Ubiquitin Ligases
E3 泛素连接酶的 ROC-Cullin 家族
  • 批准号:
    6561926
  • 财政年份:
    2003
  • 资助金额:
    $ 35.83万
  • 项目类别:
Function and Mechanism of CUL4 E3 Ligases in Human Diseases
CUL4 E3 连接酶在人类疾病中的功能和机制
  • 批准号:
    8107132
  • 财政年份:
    2003
  • 资助金额:
    $ 35.83万
  • 项目类别:

相似海外基金

Structural basis for regulation of beta2 adrenergic receptor signaling by the dynamic post-translational modification S-palmitoylation
动态翻译后修饰S-棕榈酰化调节β2肾上腺素受体信号传导的结构基础
  • 批准号:
    10603466
  • 财政年份:
    2023
  • 资助金额:
    $ 35.83万
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    RGPIN-2019-06980
  • 财政年份:
    2022
  • 资助金额:
    $ 35.83万
  • 项目类别:
    Discovery Grants Program - Individual
Glucocorticoid and Adrenergic Receptor Signaling at the Neuroimmune Interface
神经免疫界面的糖皮质激素和肾上腺素能受体信号传导
  • 批准号:
    RGPIN-2019-04706
  • 财政年份:
    2022
  • 资助金额:
    $ 35.83万
  • 项目类别:
    Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574979-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 35.83万
  • 项目类别:
    University Undergraduate Student Research Awards
Angiotensin-(1-7) and beta adrenergic receptor signaling in aging
衰老过程中血管紧张素 (1-7) 和 β 肾上腺素受体信号传导
  • 批准号:
    10629280
  • 财政年份:
    2022
  • 资助金额:
    $ 35.83万
  • 项目类别:
Angiotensin-(1-7) and beta adrenergic receptor signaling in aging
衰老过程中血管紧张素 (1-7) 和 β 肾上腺素受体信号传导
  • 批准号:
    10448574
  • 财政年份:
    2022
  • 资助金额:
    $ 35.83万
  • 项目类别:
Novel regulation of beta-adrenergic receptor function by phosphoinositide 3-kinase
磷酸肌醇 3-激酶对 β-肾上腺素能受体功能的新调节
  • 批准号:
    10591688
  • 财政年份:
    2022
  • 资助金额:
    $ 35.83万
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574984-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 35.83万
  • 项目类别:
    University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574985-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 35.83万
  • 项目类别:
    University Undergraduate Student Research Awards
The molecular mechanism of the crosstalk between the beta-2 adrenergic receptor and chemokine receptors in lymphocytes
淋巴细胞β2肾上腺素受体与趋化因子受体串扰的分子机制
  • 批准号:
    22K07118
  • 财政年份:
    2022
  • 资助金额:
    $ 35.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了